Journal article

Biomechanical Modeling to Improve Coronary Artery Bifurcation Stenting Expert Review Document on Techniques and Clinical Implementation

Antonios P Antoniadis, Peter Mortier, Ghassan Kassab, Gabriele Dubini, Nicolas Foin, Yoshinobu Murasato, Andreas A Giannopoulos, Shengxian Tu, Kiyotaka Iwasaki, Yutaka Hikichi, Francesco Migliavacca, Claudio Chiastra, Jolanda J Wentzel, Frank Gijsen, Johan HC Reiber, Peter Barlis, Patrick W Serruys, Deepak L Bhatt, Goran Stankovic, Elazer R Edelman Show all

JACC: Cardiovascular Interventions | ELSEVIER SCIENCE INC | Published : 2015


Awarded by European Commission

Funding Acknowledgements

Supported by Behrakis Foundation, and European Commission, Framework Program 7, Marie Curie International Reintegration Grant, Project: SMILE (249303). Dr. Mortier is a founder and shareholder of FEops. Dr. Tu has received a research grant from Medis. Dr. Reiber is the chief executive officer of and has equity in Medis Medical Imaging Systems. Dr. Bhatt serves on the advisory boards of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences; serves on the boards of directors of Boston VA Research Institute, Society of Cardiovascular Patient Care; chairs the American Heart Association Get With The Guidelines Steering Committee; serves on the data monitoring committees of Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Population Health Research Institute; receives honoraria from American College of Cardiology (Senior Associate Editor, Clinical Trials and News,, Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Associate Editor; Section Editor, Pharmacology), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today's Intervention), WebMD (continuing medical education steering committees), Clinical Cardiology (Deputy Editor); receives research funding from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix, Medtronic, Pfizer, Roche, Sanofi Aventis, The Medicines Company; and participates in unfunded research for FlowCo, PLx Pharma, and Takeda. Dr. Louvard has received honoraria for workshop participation from Terumo, Abbott, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.